Sexual Health in breast cancer patients in Poland

Introduction.Breast cancer is the most common malignancy among women in Poland and in the world, with a mor­tality rate second only to that of lung cancer. Breasts are one of the most important symbols of femininity and sexuality. Cancer surgery, but also systemic therapy (chemotherapy and hormone therapy) cause a change in the perception of one’s body. The aim of the survey proposed by us was to assess interest in sex by breast cancer patients during and after oncological treatment, as well as to identify ways to improve the quality of patients’ sex lives. Materials and methods.The proposed survey consisted of 3 parts: the first part included questions about the demo­graphic, in the second part there were the author’s questions about sexual dysfunction (12 questions), in the third part there was the Female Sexual Function Index (FSFI) form assessing the sexual functioning of women. The questionna­ires were made available online from October 13, 2020 to December 20, 2020 through the social networks of patient organizations involved in breast cancer care. 287 women diagnosed with breast cancer were included in the survey. Results.Before the disease almost all patients were sexually active and had a partner (95.5%; n = 274); at the time of filling the questionnaire only slightly more than half of the patients remained sexually active ( 57.1%; n = 164). About 30.7% (n = 88) stated that the disease was the main reason for not being sexually active. More than 60% of patients (60.9%; n = 137) used products to improve the comfort of sexual intercourse, mainly lubricants (39.7%; n = 114). Only about 1/3 of the patients (32.1%; n = 92) were satisfied with their sex life, 48.1% (n = 138) stated they were not satisfied with their sex life, 19.9% (n = 57) did not answer this question. The main reasons for lack of satisfaction with sex life included: decreased libido (65.9%; n = 189), vaginal dryness (55.1%; n = 158). The mean score of forms filled out by the respondents was 24.50 in FSFI form. Conclusions.Assessment of sexual dysfunction in patients with breast cancer should be performed on a routine basis before treatment and regularly during treatment